1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus SEPTEMBER 2016

Autoimmune Drug Focus SEPTEMBER 2016

  • September 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Amjevita Approval Reinforces Amgen's Biosimilar Market View
Industry Brief - Novo Nordisk Recalls Six Batches Of GlucaGen HypoKit
Industry Brief - Sotagliflozin Meets Primary Endpoint In Phase III Type I Diabetes Study
Industry Trend Analysis - Mounting Pressure Decreases Lantus' Sales Potential In 2017
Industry Brief - CHMP Recommends Marketing Authorisation For Stelara In CD
Industry Brief - FDA Approves Stelara For CD Indication
Industry Brief - Gilead Terminates GS-5745 Phase II/III Study In UC
Industry Brief - Copaxone 40mg/mL Thrice Weekly Injection Approved In Canada To Treat RRMS
Industry Trend Analysis - Secondary Progressive MS Breakthrough Revitalises Novartis Ambitions
Industry Brief - US PTO Ruling Favours Mylan In Copaxone 40mg IPR Challenge
Industry Brief - RedHill Biopharma Receives Approval Of European Patent For RHB-104 In MS
Industry Trend Analysis - Copaxone's Generic Vulnerability Increases
Industry Trend Analysis - Progressive Symptoms Will Become The Focus Of MS Drug Development
Industry Trend Analysis - Sandoz' Biosimilar Etanercept Approval Edges US Market Forward
Industry Brief - Chugai Seeks Japanese Approval For Actemra Additional Dosage In RA
Industry Brief - Orencia Granted EC Approval As RA Treatment In Adults
Industry Brief - GSK Seeks European MAA For Sirukumab In RA
Industry Brief - Samsung Gains First Health Canada Biosimilar Etanercept Approval
Industry Brief - Pfizer's Biosimilar Infliximab Achieves Positive Top-Line Results
Industry Brief - CHMP Recommends Use Of Cimzia AutoClicks Prefilled Pen
Industry Brief - Janssen Seeks Sirukumab BLA Approval In RA
Industry Brief - Daiichi Sankyo Seeks Labelling Update For Pralia In Japan
Industry Trend Analysis - Firdapse Will Tread Increasingly Fraught Line Between Access And Overheads
Industry Brief - Galectin Reports Interim Results From GR-MD-02 Phase IIa Psoriasis Trial
Industry Brief - Can-Fite's CF-101 Granted EU Patent Allowance
Industry Brief - Allergan To Acquire Vitae For Dermatologic Conditions
Industry Brief - Dosing Commences InKD025 Phase II Psoriasis Trial
Industry Brief - MacroGenics Regains Worldwide Rights To MGD01O
Industry Brief - Delinia Completes Fundraising To Advance Treg Therapy
Industry Trend Analysis - Rigel Gambling On ITP Success
Industry Brief - GSK Seeks US/EU Approval For Benlysta SC In SLE
Industry Brief - Autoimmune Conferences - December 2016

Table Of Contents

Autoimmune Drug Focus SEPTEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.